Lv11
90 积分 2024-09-05 加入
Comparison of obinutuzumab and rituximab for treating primary membranous nephropathy
1小时前
已完结
325 Obinutuzumab Use in Early Relapse of Membranous Nephropathy
5天前
已关闭
Myeloperoxidase-specific antineutrophil cytoplasmic antibody-associated vasculitis
5个月前
已完结
Proteinase 3-specific antineutrophil cytoplasmic antibody-associated vasculitis
5个月前
已完结
Standardisation of PR3-ANCA and MPO-ANCA: evaluation of certified reference materials
5个月前
已完结
Detection of antineutrophil cytoplasmic antibodies (ANCAs): a multicentre European Vasculitis Study Group (EUVAS) evaluation of the value of indirect immunofluorescence (IIF) versus antigen-specific immunoassays
5个月前
已完结
Mycophenolate mofetil versus cyclophosphamide for remission induction in ANCA-associated vasculitis: a randomised, non-inferiority trial
5个月前
已完结
Clinical Pharmacokinetics and Pharmacodynamics of Daratumumab
8个月前
已完结
Membranous nephropathy—diagnosis and identification of target antigens
8个月前
已完结
Telitacicept: First Approval
8个月前
已完结
皖公网安备34019202002308
